Amplia Therapeutics Limited Stock: price and insider trades · Australia
Amplia Therapeutics Limited: what insiders have been doing
Amplia Therapeutics Limited is a Health Care company. Its directors and officers file their transactions with ASX. Over the twelve months to 26 October 2026, 3 filings were filed, from 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Over the last twelve months, not one insider purchase of Amplia Therapeutics Limited stock was filed.
With 3 filings in twelve months, the company is quieter than the median of 5 filings across the 1,598 companies we follow on the same exchange.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
- ShareASXISIN AU0000023822ASX:2924-03108237-2A1682827
- ShareASXISIN AU0000023822ASX:2924-03103643-2A1679269
- ShareASXASX:2924-03103443-2A1679057
3 of 3 declarations
About Amplia Therapeutics Limited
Amplia Therapeutics Limited is a company listed on the XASX, focused on developing treatments for serious diseases. It concentrates on innovative therapies based on regenerative medicine approaches.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
